Claims
- 1. A composition comprising (a) a polynucleotide or its derivative thereof, (b) at least one polyanionic polymer, and (c) at least one amphiphilic block copolymer.
- 2. The composition of claim 1, wherein said at least one amphiphilic block copolymer is a block copolymer of poly(oxyethylene) and poly(oxypropylene).
- 3. The composition of claim 2, wherein said at least one amphiphilic block copolymer contains at least one poly(oxyethylene) and poly(oxypropylene) block copolymer with oxyethylene content of 50% or less, and at least one poly(oxyethylene) and poly(oxypropylene) block copolymer with oxyethylene content of 50% or more.
- 4. The composition of claim 1, wherein said amphiphilic block copolymer is selected from the group of block copolymers having the formulae (I), (II), (III) and (IV):
- 5. The composition of claim 1, wherein said anionic polymer has a plurality of anionic repeating units.
- 6. A polynucleotide composition comprising (a) a polynucleotide or derivative thereof and (b) a block copolymer having a polyether segment and a polyanion segment.
- 7. The composition of claim 6, further comprising a polyanionic polymer.
- 8. The composition of claim 6, wherein said block copolymer is selected from the group of polymers having the formulae (V-a), (VI-a), (VII), (VIII-a), (V-b), (VI-b), (VIII-b), (VIII-c) and (VIII-d):
- 9. The composition of claim 6, wherein said polyanion segments are combined with poloxamers and comprises at least three of the same or different repeating unites containing at least one atom selected from the group consisting of oxygen, sulfur, or phosphorus.
- 10. The composition of claim 6, wherein said polyanion segment is selected from the group consisting of polymethacrylic acid and its salts, polyacrylic acid and its salts, copolymers of methacrylic acids and its salts, copolymers of acrylic acid and its salts, heparin, poly(phosphate) and polyamino acid.
- 11. A method of delivering a polynucleotide or its derivative to a cell comprising administering a composition of claim 1.
- 12. A method of delivering a polynucleotide or its derivative to a cell comprising administering a composition of claim 6.
- 13. A method of treating a human or an animal comprising administering the composition according to claim 1.
- 14. The method of claim 13, wherein the composition is administered orally, topically, rectally, vaginally, parenterally, intramuscularly, intradermally, subcutaneously, intraparitoneally, or intravenously, or by pulmonary route by use of an aerosol, or parenterally.
- 15. The method of claim 13, wherein said composition is administered to at least one of smooth, skeletal, and cardiac muscles.
- 16. A method of treating a human or an animal comprising administering the composition according to claim 6.
- 17. The method of claim 16, wherein the composition is administered orally, topically, rectally, vaginally, parenterally, intramuscularly, intradermally, subcutaneously, intraparitoneally, or intravenously, or by pulmonary route by use of an aerosol, or parenterally.
- 18. The method of claim 16, wherein said composition is administered to at least one of smooth, skeletal, and cardiac muscles.
- 19. A method of treating a human or an animal comprising intradermally administering the composition of claim 1.
- 20. A method of treating a human or an animal comprising intradermally administering the composition of claim 6.
Parent Case Info
[0001] This application claims the benefit of U.S. Provisional Application No. 60/344,075, filed on Dec. 28, 2001, the content of which is hereby incorporated by reference.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60344075 |
Dec 2001 |
US |